These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 27270651)
81. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Dayal S; Wilson KM; Motto DG; Miller FJ; Chauhan AK; Lentz SR Circulation; 2013 Mar; 127(12):1308-16. PubMed ID: 23426106 [TBL] [Abstract][Full Text] [Related]
82. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Ball J; Carrington MJ; McMurray JJ; Stewart S Int J Cardiol; 2013 Sep; 167(5):1807-24. PubMed ID: 23380698 [TBL] [Abstract][Full Text] [Related]
83. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828 [TBL] [Abstract][Full Text] [Related]
84. TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. Santilli F; Mucci L; Davì G Intern Emerg Med; 2011 Jun; 6(3):203-12. PubMed ID: 20734162 [TBL] [Abstract][Full Text] [Related]
86. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Eikelboom JW; Hankey GJ; Thom J; Bhatt DL; Steg PG; Montalescot G; Johnston SC; Steinhubl SR; Mak KH; Easton JD; Hamm C; Hu T; Fox KA; Topol EJ; Circulation; 2008 Oct; 118(17):1705-12. PubMed ID: 18838564 [TBL] [Abstract][Full Text] [Related]
87. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451 [TBL] [Abstract][Full Text] [Related]
88. Hydrogen peroxide is involved in collagen-induced platelet activation. Pignatelli P; Pulcinelli FM; Lenti L; Gazzaniga PP; Violi F Blood; 1998 Jan; 91(2):484-90. PubMed ID: 9427701 [TBL] [Abstract][Full Text] [Related]
89. Physiologic variables affecting thromboxane B2 production in human whole blood. Alessandrini P; Avogaro P; Bittolo Bon G; Patrignani P; Patrono C Thromb Res; 1985 Jan; 37(1):1-8. PubMed ID: 3983893 [TBL] [Abstract][Full Text] [Related]
90. Eicosenoid biosynthesis and platelet function with advancing age. Reilly IA; FitzGerald GA Thromb Res; 1986 Feb; 41(4):545-54. PubMed ID: 3754355 [TBL] [Abstract][Full Text] [Related]
91. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Catella F; Healy D; Lawson JA; FitzGerald GA Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463 [TBL] [Abstract][Full Text] [Related]
92. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. FitzGerald GA Am J Cardiol; 1991 Sep; 68(7):11B-15B. PubMed ID: 1892057 [TBL] [Abstract][Full Text] [Related]
93. Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation. Pastori D; Pignatelli P; Farcomeni A; Nocella C; Bartimoccia S; Carnevale R; Violi F Oncotarget; 2016 Jun; 7(26):39143-39147. PubMed ID: 27270651 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]